Open for recruitment
Trial summary
The purpose of this study is to evaluate the safety and tolerability of: a) Casdatifan when taken alone in participants with advanced solid tumor malignancies and clear cell renal cell carcinoma (ccRCC) during the dose escalation stage and; b) Casdatifan monotherapy and casdatifan in combination with cabozantinib in participants with ccRCC in the dose expansion stage.
Trial details
Short title
ARC-20
Diagnosis
Advanced solid tumours
Type of treatment
Medical Oncology
Phase
I
Who can participate
Clinical trials can have restrictive criteria of who can and can’t participate, talk to your healthcare provider if you are interested in this clinical trial.